| 1. |
de Salvo G, Vaz-Pereira S, Keane PA, et al. Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy[J]. Am J Ophthalmol, 2014, 158(6): 1228-1238. DOI: 10.1016/j.ajo.2014.08.025.
|
| 2. |
Koizumi H, Yamagishi T, Yamazaki T, et al. Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability[J]. Am J Ophthalmol, 2013, 155(2): 305-313. DOI: 10.1016/j.ajo.2012.07.018.
|
| 3. |
Jirarattanasopa P, Ooto S, Nakatak I, et al. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneratation and polypoidal choroidal vasculopathy[J]. Invest Ophthalmol Vis Sci, 2012, 53(7): 3663-3672. DOI: 10.1167/iovs.12-9619.
|
| 4. |
于珊珊, 刘文. 中心性浆液性脉络膜视网膜病变[M]//刘文, 文峰, 易长贤. 临床眼底病内科卷. 北京: 人民卫生出版社, 2015: 379-394.Yu SS, Liu W. Central serous chorioretinopathy[M]//Liu W, Wen F, Yi CX. Diseases of clinical ocular fundus. Beijing: People’s Medical Publishing House, 2015: 379-394.
|
| 5. |
Hamzah F, Shinojima A, Mori R, et al. Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy[J]. BMC Ophthalmol, 2014, 14: 145. DOI: 10.1186/1471-2415-14-145.
|
| 6. |
张新媛, 赖旭佑.关注黄斑区肥厚型脉络膜疾病谱的概念及研究[J]. 中华实验眼科杂志, 2017, 35(1): 385-390. DOI: 10.3760/cma.j.issn.2095-0160.2017.05.001.Zhang XY, Lai XY. Paying attention to the concept and research of pachychoroid disease spectrum[J]. Chin J Exp Ophthalmol, 2017, 35(1): 385-390. DOI: 10.3760/cma.j.issn.2095-0160.2017.05.001.
|
| 7. |
Toyama T, Ohtomo K, Noda Y, et al. Polypoidal choroidal vasculopathy and history of central serous chorioretinopathy[J]. Eye (Lond), 2014, 28(8): 992-997. DOI: 10.1038/eye.2014.132.
|
